Association of patient out-of-pocket costs with prescription abandonment and delay in fills of novel oral anticancer agents
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Research brief (Leonard Davis Institute of Health Economics)
- Author(s):
- Doshi, Jalpa A., author Li, Pengxiang, author Huo, Hairong, author Pettit, Amy R., author Armstrong, Katrina A., author
- Contributor(s):
- Leonard Davis Institute of Health Economics, issuing body.
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2018
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Antineoplastic Agents -- economics Antineoplastic Agents -- therapeutic use Drug Costs Financing, Personal -- statistics & numerical data Medication Adherence -- statistics & numerical data Administration, Oral Antineoplastic Agents -- administration & dosage Health Services Accessibility Prescription Drugs -- economics Socioeconomic Factors Time Factors Humans United States
- Genre(s):
- Technical Report
- Abstract:
- High out-of-pocket (OOP) costs may limit access to novel oral cancer medications. In a retrospective study, nearly one third of patients whose OOP costs were $100 to $500 and nearly half of patients whose OOP costs were more than $2,000 failed to pick up their new prescription for an oral cancer medication, compared to 10% of patients who were required to pay less than $10 at the time of purchase. Delays in picking up prescriptions were also more frequent among patients facing higher OOP costs.
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
- 1 online resource (1 PDF file (2 unnumbered pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 101720127 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101720127